Association Between Proton Pump Inhibitor Use and Biliary Tract Cancer Risk: A Swedish Population‐Based Cohort Study
Habiba Kamal, Omid Sadr‐Azodi, Lars Engstrand, Nele Brusselaers – 20 May 2021
Combination of Model for End‐Stage Liver Disease and Lactate Predicts Death in Patients Treated With Salvage Transjugular Intrahepatic Portosystemic Shunt for Refractory Variceal Bleeding
Aurélie Walter, Marika Rudler, Pol Olivas, Lucile Moga, Eric Trépo, Marie Angèle Robic, Isabelle Ollivier‐Hourmand, Anna Baiges, Olivier Sutter, Charlotte Bouzbib, Jean Marie Peron, Vincent Le Pennec, Nathalie Ganne‐Carrié, Juan Carlos Garcia‐Pagán, Maxime Mallet, Hélène Larrue, Thong Dao, Dominique Thabut, Virginia Hernández‐Gea, Jean‐Charles Nault, Christophe Bureau, Manon Allaire, the Salvage TIPS Group – 20 May 2021
LiverLearning®: 2021 Webinar: Challenges in NASH Clinical Trials
Join the Nonalcoholic Fatty Liver Disease Special Interest Group in discussing the current challenges in histological assessment in NASH clinical trials. Presenters will also discuss how to implement hard outcomes in NASH clinical trials and the use non-invasive biomarkers as primary endpoints for drug approval.Naim Alkhouri Naim Alkhouri, MD is the VP of Academic Affairs, Chief of Transplant Hepatology, and Director of the Fatty Liver Program at Arizona Liver Health (ALH) in Phoenix, AZ. Prior to joining ALH, Dr.
COVID‐19‐Related Downscaling of In‐Hospital Liver Care Decreased Patient Satisfaction and Increased Liver‐Related Mortality
Lukas Hartl, Georg Semmler, Benedikt Silvester Hofer, Nawa Schirwani, Mathias Jachs, Benedikt Simbrunner, David Josef Maria Bauer, Teresa Binter, Katharina Pomej, Matthias Pinter, Michael Trauner, Mattias Mandorfer, Thomas Reiberger, Bernhard Scheiner – 17 May 2021 – The coronavirus disease 2019 (COVID‐19) pandemic necessitated down‐scaling of in‐hospital care to prohibit the spread of severe acute respiratory syndrome–coronavirus‐2.
Recurrence of Primary Sclerosing Cholangitis After Liver Transplant in Children: An International Observational Study
Mercedes Martinez, Emily R. Perito, Pamela Valentino, Cara L Mack, Madeleine Aumar, Annemarie Broderick, Laura G. Draijer, Eleonora D.T. Fagundes, Katryn N. Furuya, Nitika Gupta, Simon Horslen, Maureen M. Jonas, Binita M. Kamath, Nanda Kerkar, Kyung Mo Kim, Kaija‐Leena Kolho, Bart G.P. Koot, Trevor J. Laborda, Christine K. Lee, Kathleen M. Loomes, Tamir Miloh, Douglas Mogul, Saeed Mohammed, Nadia Ovchinsky, Girish Rao, Amanda Ricciuto, Alexandre Rodrigues Ferreira, Kathleen B. Schwarz, Vratislav Smolka, Atsushi Tanaka, Mary E.M. Tessier, Venna L. Venkat, Bernadette E.
Maternal Early‐Pregnancy Glucose Concentrations and Liver Fat Among School‐Age Children
Madelon L. Geurtsen, Rama J. Wahab, Janine F. Felix, Romy Gaillard, Vincent W.V. Jaddoe – 17 May 2021
Admission Urinary and Serum Metabolites Predict Renal Outcomes in Hospitalized Patients With Cirrhosis
Jasmohan S. Bajaj, Guadalupe Garcia‐Tsao, K. Rajender Reddy, Jacqueline G. O’Leary, Hugo E. Vargas, Jennifer C. Lai, Patrick S. Kamath, Puneeta Tandon, Ram M. Subramanian, Paul Thuluvath, Andrew Fagan, Tejasav Sehrawat, Randolph Rosa Rodriguez, Leroy R. Thacker, Florence Wong – 17 May 2021
Letter to the Editor: The Role of Surgery in Multiple Intrahepatic Cholangiocarcinoma Should Not Be Dismissed Without Further Analysis
Hannes Jansson, Ernesto Sparrelid – 17 May 2021
Spatiotemporal Phylodynamics of Hepatitis C Among People Who Inject Drugs in India
Steven J. Clipman, Shruti H. Mehta, Mary A. Rodgers, Priya Duggal, Aylur K. Srikrishnan, Shanmugam Saravanan, Pachamuthu Balakrishnan, Canjeevaran K. Vasudevan, Stuart C. Ray, Muniratnam S. Kumar, Thomas C. Quinn, Gavin A. Cloherty, Gregory M. Lucas, Sunil S. Solomon – 17 May 2021
Sofosbuvir, Glecaprevir, Pibrentasvir, and Ribavirin as a Rescue Therapy in Difficult‐to‐Treat HCV Patients
Magdalena Meszaros, Régine Truchi, Denis Ouzan, Albert Tran, Marc Bourlière, Georges‐Philippe Pageaux – 17 May 2021